Medpace Holdings (MEDP) Shares Outstanding (Weighted Average) (2015 - 2026)

Medpace Holdings has reported Shares Outstanding (Weighted Average) for 12 years, with the latest figure at $28.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 6.39% year-over-year to $28.4 million; the trailing twelve-month figure through Mar 2026 stood at $28.4 million (down 6.39% YoY), and the FY2025 full-year result was $28.8 million, down 6.82% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $28.4 million, down from $28.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $34.9 million in Q1 2022, with the low at $28.1 million in Q3 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $30.8 million across 5 years, with a median of $30.8 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) fell 11.2% — and 2024, when it rose 0.77%.
• Medpace Holdings' Shares Outstanding (Weighted Average) stood at $32.4 million in 2022, then retreated by 5.14% to $30.7 million in 2023, then rose by 0.76% to $31.0 million in 2024, then slipped by 6.82% to $28.8 million in 2025, then dropped by 1.39% to $28.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.4 million (Q1 2026), $28.8 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.